Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

OLMA – olema pharmaceuticals, inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OLMA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/16
04:04 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Medium Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Report
3/16
12:44 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Low Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Report
3/16
07:19 am
olma
Form S-8 Olema Pharmaceuticals,
High Report
Form S-8 Olema Pharmaceuticals,
Report
3/16
07:11 am
olma
Form 10-K Olema Pharmaceuticals, For: Dec 31
High Report
Form 10-K Olema Pharmaceuticals, For: Dec 31
Report
3/16
07:05 am
olma
Form 8-K Olema Pharmaceuticals, For: Mar 16
High Report
Form 8-K Olema Pharmaceuticals, For: Mar 16
Report
3/11
04:20 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Medium Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Report
3/10
12:28 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Medium Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Report
3/9
03:16 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Neutral Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Report
3/6
10:05 am
olma
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: FMR LLC
Low Report
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: FMR LLC
Report
3/5
08:00 pm
olma
Form 4 Olema Pharmaceuticals, For: Mar 03 Filed by: Mitchell Shawnte
Medium Report
Form 4 Olema Pharmaceuticals, For: Mar 03 Filed by: Mitchell Shawnte
Report
3/4
02:19 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Low Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Report
3/4
10:21 am
olma
Form 144 Olema Pharmaceuticals, Filed by: Mitchell Shawnte
Low Report
Form 144 Olema Pharmaceuticals, Filed by: Mitchell Shawnte
Report
3/3
03:00 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Mitchell Shawnte
Low Report
Form 144 Olema Pharmaceuticals, Filed by: Mitchell Shawnte
Report
2/27
04:39 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Low Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Report
2/24
03:47 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Low Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Report
2/23
04:33 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Low Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Report
2/23
02:34 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Low Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Report
2/17
09:35 pm
olma
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Austin Sasha Lu
Low Report
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Austin Sasha Lu
Report
2/17
09:33 pm
olma
Form 3 Olema Pharmaceuticals, For: Jan 30 Filed by: Austin Sasha Lu
Low Report
Form 3 Olema Pharmaceuticals, For: Jan 30 Filed by: Austin Sasha Lu
Report
2/17
04:37 pm
olma
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: JANUS HENDERSON GROUP PLC
Low Report
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: JANUS HENDERSON GROUP PLC
Report
2/17
04:31 pm
olma
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
Low Report
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Bain Capital Life Sciences Opportunities IV, L.P.
Report
2/13
08:50 am
olma
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Deep Track Capital, LP
Medium Report
Form SCHEDULE 13G/A Olema Pharmaceuticals, Filed by: Deep Track Capital, LP
Report
2/12
02:55 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Low Report
Form 144 Olema Pharmaceuticals, Filed by: Kovacs Shane William Charles
Report
2/5
01:32 pm
olma
Form SCHEDULE 13G Olema Pharmaceuticals, Filed by: FMR LLC
Low Report
Form SCHEDULE 13G Olema Pharmaceuticals, Filed by: FMR LLC
Report
2/4
09:30 pm
olma
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Myles David C.
Low Report
Form 4 Olema Pharmaceuticals, For: Feb 02 Filed by: Myles David C.
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0